by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Research
Treatment was generally well tolerated. Relative to baseline, marked reductions in depressive symptoms were observed for the first 5 weeks post-treatment (Cohen’s d = 2.2 at week 1 and 2.3 at week 5, both p < 0.001); nine and four patients met the criteria...
by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Research
Two main change processes were identified in relation to the treatment. The first concerned change from disconnection (from self, others, and world) to connection, and the second concerned change from avoidance (of emotion) to acceptance. A third theme concerned...
by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Research
Decreased depressive symptoms were observed in all 19 patients at 1-week post-treatment and 47% met criteria for response at 5 weeks. Whole-brain analyses revealed post-treatment decreases in CBF in the temporal cortex, including the amygdala. Decreased amygdala CBF...
by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Research
Further research on this direction is needed in order to better understand the properties of tryptamines like DMT and their biophysical effects and implications on human perception and brain communication. Read from original source
by EmpathiCSubstanceS | Aug 11, 2022 | Psychedelic Research
We conclude that the function of DMT may extend central nervous activity and involve a more universal role in cellular protective mechanisms. Suggestions are offered for future directions of indole alkaloid research in the general medical field. We provide converging...
